| P2093 | author name string | U Klotz | |
| | I Walter-Sack | |
| P2860 | cites work | Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. | Q24541291 |
| | Clinical pharmacokinetics of levodopa in parkinson's disease | Q28329436 |
| | Influence of food on the bioavailability of spironolactone | Q34190095 |
| | Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. | Q34330493 |
| | Physiological and pharmacological variability in estimated hepatic blood flow in man. | Q34448582 |
| | The gut wall metabolism of ethinyloestradiol and its contribution to the pre-systemic metabolism of ethinyloestradiol in humans | Q34450130 |
| | The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol | Q34511610 |
| | Influence of dietary protein and carbohydrate on phenytoin metabolism in man | Q34518309 |
| | Drug metabolism in white vegetarians | Q34518604 |
| | Interaction of citrus juices with felodipine and nifedipine | Q34567652 |
| | Stable oral availability of sustained release propranolol when co-administered with hydralazine or food: evidence implicating substrate delivery rate as a determinant of presystemic drug interactions | Q34620717 |
| | Dietary influences on the kinetics of antipyrine and aminopyrine in human subjects | Q34620945 |
| | Interaction of ethinyloestradiol with ascorbic acid in man. | Q34779536 |
| | Interactions between nutritional factors and drug biotransformations in man | Q35012384 |
| | Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors | Q35372195 |
| | What is "fasting" drug administration? On the role of gastric motility in drug absorption | Q35898955 |
| | No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day), 5-FU infusion | Q35993200 |
| | Metabolic aspects of antioxidants and preservatives | Q36463742 |
| | Dietary regulation of cytochrome P450. | Q37355701 |
| | The model drug approach in clinical pharmacology | Q37368198 |
| | Malnutrition and drugs: clinical implications. | Q37835422 |
| | Research review. Interactions between environmental chemicals and drug biotransformation in man. | Q37855993 |
| | Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics | Q37913119 |
| | Letter: Pyridoxine and serum concentration of phenytoin and phenobarbitone | Q39367386 |
| | Influence of Food on the Bioavailability of Drugs | Q39510492 |
| | Influence of food on the presystemic metabolism of drugs | Q39537307 |
| | Influences of diet and nutrition on clinical pharmacokinetics | Q39604181 |
| | Age and diet effects on drug action | Q39646227 |
| | Effects of cancer disease on the metabolism of anticancer agents. | Q39646239 |
| | Clinical pharmacokinetics of anti-parkinsonian drugs | Q39673262 |
| | The antipyrine test in clinical pharmacology: Conceptions and misconceptions | Q39676489 |
| | The influence of nutrition on the systemic availability of drugs. Part I: Drug absorption | Q39691332 |
| | The influence of nutrition on the systemic availability of drugs. Part II: Drug metabolism and renal excretion | Q39691344 |
| | Nutrition and chemical biotransformations in man | Q39708322 |
| | Regulation of drug metabolism in man by environmental factors | Q39808600 |
| | Nutrient effects on drug metabolism and action in the elderly | Q39837195 |
| | Clinical pharmacokinetics of oral contraceptive steroids | Q40149127 |
| | Influence of Food Intake on Presystemic Clearance of Drugs | Q40157652 |
| | The effect of nutritional factors on hepatic drug and toxicant metabolism | Q40182796 |
| | Complex effects of diet on drug disposition | Q40184307 |
| | Effect of protein-energy malnutrition on drug metabolism in man. | Q40213553 |
| | Interactions between nutrition, food and drugs in man. | Q40213558 |
| | Inhibitors of chemical carcinogens. | Q40286073 |
| | The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature | Q40484461 |
| | Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications | Q40640558 |
| | Assessment of liver metabolic function. Clinical implications | Q40648534 |
| | Extrahepatic metabolism of drugs in humans | Q40743025 |
| | Grapefruit juice and drugs. How significant is the interaction? | Q40743038 |
| | Clinical importance of hepatic cytochrome P450 in drug metabolism | Q40923015 |
| | Lack of acute effect on lidocaine pharmacokinetics from parenteral nutrition. | Q41193517 |
| | Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles | Q41387458 |
| | Hepatic drug clearance in children with leukemia: changes in clearance of model substrates during remission-induction therapy | Q41445649 |
| | Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis | Q41473934 |
| | Effects of hydralazine, nitroglycerin, and food on estimated hepatic blood flow | Q41488856 |
| | Effect of carbohydrates on estimated hepatic blood flow | Q41594706 |
| | The effect of individual dietary constituents on antipyrine clearance in Asian immigrants [proceedings] | Q41606687 |
| | Effect of food on hepatic blood flow: implications in the "food effect" phenomenon | Q41608956 |
| | Effect of food on lidocaine kinetics: Mechanism of food-related alteration in high intrinsic clearance drug elimination | Q41638310 |
| | Effect of vitamin C supplement on antipyrine disposition in man. | Q41857500 |
| | Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man | Q41905249 |
| | Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery | Q42017833 |
| | Megadose vitamin C and metabolic effects of the pill. | Q42358943 |
| | The effect of ascorbic acid on the sulphate conjugation of ingested noradrenaline and dopamine | Q42532070 |
| | Food and nifedipine pharmacokinetics | Q43228835 |
| | Effect of a high protein meal on the bioavailability of verapamil | Q43240331 |
| | Effects of feeding on the systemic clearance of indocyanine green and propranolol blood concentrations and plasma binding | Q43261729 |
| | Influence of food on the bioavailability of a sustained-release verapamil preparation | Q43570488 |
| | Effects of parenteral amino acid nutritional regimens on oxidative and conjugative drug metabolism. | Q43640416 |
| | Concomitant food intake does enhance the bioavailability and effect of hydralazine | Q43703499 |
| | Drug oxidation in Asian vegetarians | Q43703765 |
| | Effects of folic acid on phenytoin kinetics in healthy subjects | Q43774309 |
| | Enhanced phenacetin metabolism in human subjects fed charcoal-broiled beef | Q44171887 |
| | Diet and cimetidine induce comparable changes in theophylline metabolism in normal subjects | Q44181152 |
| | Disposition of single oral doses of butylated hydroxytoluene in man and rat. | Q44454047 |
| | High-fat meals increase the clearance of cyclosporine | Q44515223 |
| | Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine--and its potential clinical relevance | Q44754266 |
| | Effects of GRAS substances on pharmacologic effects of drugs | Q45397912 |
| | Disposition of salicylic acid in malnourished Ethiopian children after single oral dose | Q46524545 |
| | Environmental effects on antipyrine half-life in man. | Q46532923 |
| | Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans | Q46859122 |
| | Acquired warfarin resistance and weight-reducing diet | Q47284367 |
| | Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice | Q48809052 |
| | Health and ecological assessment of polynuclear aromatic hydrocarbons | Q51221821 |
| | Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity. | Q51593328 |
| | Interaction between grapefruit juice and midazolam in humans* | Q51599931 |
| | A randomized study of propranolol on postprandial portal hyperemia in cirrhotic patients. | Q51606614 |
| | Evaluation of postprandial hyperemia in superior mesenteric artery and portal vein in healthy and cirrhotic humans: an operator-blind echo-Doppler study. | Q51611324 |
| | Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serum. | Q51616706 |
| | Concomitant food intake can increase the bioavailability of propranolol by transient inhibition of its presystemic primary conjugation. | Q51633368 |
| | Influence of food on the bioavailability of "real" and "apparent" hydralazine from conventional and slow-release preparations. | Q51652849 |
| | The effect of brassica vegetable consumption on caffeine metabolism in humans | Q53750676 |
| | Pharmacokinetics of aspirin in African children with normal nutrition and malnutrition | Q53860531 |
| | Antipyrine metabolism in African villagers. | Q53899060 |
| | Effects of changing liver blood flow by exercise and food on kinetics and dynamics of saruplase. | Q54011930 |
| | Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administration. | Q55063024 |
| | Modification of drug biotransformation by vitamin C in man | Q59095082 |
| | Antipyrine as a probe for human oxidative drug metabolism: Identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation* | Q60787070 |
| | ??? | Q64878121 |
| | Nutrition and oxidative drug metabolism in man: relative influence of dietary lipids, carbohydrate, and protein | Q66940722 |
| | Pyridoxine reversal of L-dopa effects in Parkinsonism. | Q67215488 |
| | Folate Deficiency after Anticonvulsant Drugs: An Effect of Hepatic Enzyme Induction? | Q67274051 |
| | Effect of charcoal-broiled beef on antipyrine and theophylline metabolism | Q67289528 |
| | Stimulatory effect of brussels sprouts and cabbage on human drug metabolism | Q67463132 |
| | Enhancement of hydralazine bioavailability by food | Q67585403 |
| | Enhancement of the bioavailability of propranolol and metoprolol by food | Q67585406 |
| | Pharmacokinetics of metronidazole in severely malnourished and nutritionally rehabilitated children | Q67732395 |
| | Effect of charcoal-broiled beef on phenacetin metabolism in man | Q67842649 |
| | Effects of protein and carbohydrate content of diet on drug conjugation | Q68004966 |
| | Theophylline plasma clearance in critically ill geriatric patients receiving total parenteral nutrition and in control patients | Q68363028 |
| | A comparison of the effects of a macrobiotic diet and a Western diet on drug metabolism and plasma lipids in man | Q68687401 |
| | The effect of dietary energy and protein deficiency on drug metabolism | Q68859233 |
| | Effect of subacute oral intake of the food antioxidant butylated hydroxyanisole on clinical parameters and phase-I and -II biotransformation capacity in man | Q69394288 |
| | Influence of food on the pharmacokinetics of quinapril and its active diacid metabolite, CI-928 | Q69473762 |
| | Effects of dietary protein on theophylline pharmacokinetics and caffeine and aminopyrine breath tests | Q69567240 |
| | Increased clearance of propranolol and theophylline by high-protein compared with high-carbohydrate diet | Q69783904 |
| | Hepatic antipyrine metabolism in malnourished patients: influence of the type of malnutrition and course after nutritional rehabilitation | Q69948443 |
| | Stimulation of oxidative drug metabolism by parenteral refeeding of nutritionally depleted patients | Q69950098 |
| | The effect of total parenteral nutrition on hepatic drug oxidation | Q70374597 |
| | Effects of semisynthetic diets on xenobiotic metabolizing enzyme activity and morphology of small intestinal mucosa in humans | Q70475079 |
| | Effects of parenteral nutritional regimens on oxidative drug metabolism | Q70483063 |
| | Influence of dietary purines on the metabolism of allopurinol in man | Q70604338 |
| | Myocardial infarction after diet-induced warfarin resistance | Q70638351 |
| | Grapefruit juice--felodipine interaction: mechanism, predictability, and effect of naringin | Q70766724 |
| | Reduction of first-pass hepatic clearance of propranolol by food | Q70791153 |
| | Food-induced increase in propranolol bioavailability—Relationship to protein and effects on metabolites | Q70999671 |
| | The influence of changes in dietary fat on the clearance of antipyrine and 4-hydroxylation of debrisoquine | Q71154514 |
| | Analysis of polycyclic aromatic hydrocarbons in UK total diets | Q71239976 |
| | Effect of brussels sprouts and cabbage on drug conjugation | Q71257709 |
| | Mechanism by which hydralazine increases propranolol bioavailability | Q71295453 |
| | Inter- and intra-subject variation in the first-pass elimination of highly cleared drugs during chronic dosing. Studies with deuterated verapamil | Q71324315 |
| | Effect of food on blood hydralazine levels and response in hypertension | Q71388615 |
| | Effect of dietary protein and carbohydrate on theophylline metabolism in children | Q71450121 |
| | Warfarin resistance caused by broccoli | Q71714646 |
| | Acetaminophen metabolism in subjects fed charcoal-broiled beef | Q71823237 |
| | Grapefruit juice inhibits 7-hydroxylation of coumarin in healthy volunteers | Q72079867 |
| | The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients | Q72113281 |
| | Effect of dietary fat on the pharmacokinetics and pharmacodynamics of cyclosporine in kidney transplant recipients | Q72146673 |
| | Disposition of intravenous and oral cyclosporine after administration with grapefruit juice | Q72281174 |
| | Human hepatic cytochrome P-450 composition as probed by in vitro microsomal metabolism of warfarin | Q72588344 |
| | Influence of folic acid on blood-phenytoin levels | Q93694688 |
| P433 | issue | 1 | |
| P304 | page(s) | 47-64 | |
| P577 | publication date | 1996-07-01 | |
| P1433 | published in | Clinical Pharmacokinetics | Q5133788 |
| P1476 | title | Influence of diet and nutritional status on drug metabolism | |
| P478 | volume | 31 | |